EUVIMEDEUVIMED entdecken
Crossref

THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM

Mohamed Raslan

Al-Azhar Journal of Pharmaceutical Sciences · 01.09.2012 · 46 (2) · 90-99

DOI: 10.21608/ajps.2012.7119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Azhar Journal of Pharmaceutical Sciences, online erschienen am 01.09.2012. Verfasst von Mohamed Raslan. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to formulate sustained release tablet dosage form (100 mg) using Ketoprofen Niosomes. Ketoprofen Niosomes were prepared by lipid hydration method and then dried and compressed into sustained release tablets (100 mg). The tablet excipients employed include: Avicel PH 101, Avicel PH 102, and Mannitol as diluents, Cab-O-Sil (colloidal silica) as a glidant, Starch as a disintegrant and Magnesium Stearate as lubricating agent. The tablets were tested for weight variation, hardness, friability, thickness, disintegration, drug content and release ratio. Finally the release kinetics of Ketoprofen tablets were calculated.

Zitieren

APA

Raslan, M. (2012). THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM. Al-Azhar Journal of Pharmaceutical Sciences, 46(2), 90-99. https://doi.org/10.21608/ajps.2012.7119

Vancouver

Raslan M. THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM. Al-Azhar Journal of Pharmaceutical Sciences. 2012;46(2):90-99. doi:10.21608/ajps.2012.7119

BibTeX
@article{Raslan2012,
  author = {Raslan, Mohamed},
  title = {THE USE OF KETOPROFEN NIOSOMES FOR FORMULATION OF SUSTAINED RELEASE TABLET DOSAGE FORM},
  journal = {Al-Azhar Journal of Pharmaceutical Sciences},
  year = {2012},
  volume = {46},
  number = {2},
  pages = {90--99},
  doi = {10.21608/ajps.2012.7119}
}
Kostenlos starten →